These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28638707)

  • 21. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual Dysfunction and Incidence of Depression in Multiple Sclerosis Patients.
    Zavoreo I; Gržinčić T; Preksavec M; Madžar T; Bašić Kes V
    Acta Clin Croat; 2016 Sep; 55(3):402-406. PubMed ID: 29045103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis.
    Jongen PJ; Wesnes K; van Geel B; Pop P; Sanders E; Schrijver H; Visser LH; Gilhuis HJ; Sinnige LG; Brands AM;
    PLoS One; 2014; 9(5):e96444. PubMed ID: 24787714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
    Nygaard GO; Walhovd KB; Sowa P; Chepkoech JL; Bjørnerud A; Due-Tønnessen P; Landrø NI; Damangir S; Spulber G; Storsve AB; Beyer MK; Fjell AM; Celius EG; Harbo HF
    Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLEEP DISORDERS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS.
    Odintsova TA; Kopchak OO
    Wiad Lek; 2021; 74(2):257-262. PubMed ID: 33813482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fatigue in multiple sclerosis relapsing-remitting form].
    Mendes MF; Tilbery HP; Balsimell S; Felipe E; Moreira MA; Barão-Cruz AM
    Arq Neuropsiquiatr; 2000 Jun; 58(2B):471-5. PubMed ID: 10920409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
    Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
    Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction.
    Fragalà E; Russo GI; Di Rosa A; Giardina R; Privitera S; Favilla V; Castelli T; Chisari M; Caramma A; Patti F; Cimino S; Morgia G
    Eur J Neurol; 2015 Mar; 22(3):485-92. PubMed ID: 25410608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
    Sandi D; Biernacki T; Szekeres D; Füvesi J; Kincses ZT; Rózsa C; Mátyás K; Kása K; Matolcsi J; Zboznovits D; Burány Z; Langane É; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2017 Oct; 17():57-62. PubMed ID: 29055476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of sexual dysfunction in men and women with multiple sclerosis.
    Fraser C; Mahoney J; McGurl J
    J Neurosci Nurs; 2008 Oct; 40(5):312-7. PubMed ID: 18856253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, dimensions, and predictor factors of sexual dysfunction in women of Iran Multiple Sclerosis Society: a cross-sectional study.
    Ghasemi V; Simbar M; Ozgoli G; Nabavi SM; Alavi Majd H
    Neurol Sci; 2020 May; 41(5):1105-1113. PubMed ID: 31897948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.
    Calabrese M; Rinaldi F; Grossi P; Mattisi I; Bernardi V; Favaretto A; Perini P; Gallo P
    Mult Scler; 2010 Oct; 16(10):1220-8. PubMed ID: 20670981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?
    Barin L; Salmen A; Disanto G; Babačić H; Calabrese P; Chan A; Kamm CP; Kesselring J; Kuhle J; Gobbi C; Pot C; Puhan MA; von Wyl V;
    Mult Scler Relat Disord; 2018 Oct; 25():112-121. PubMed ID: 30059895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.
    Diržiuvienė B; Mickevičienė D
    Mult Scler Relat Disord; 2022 Mar; 59():103558. PubMed ID: 35123292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.
    Janardhan V; Bakshi R
    J Neurol Sci; 2002 Dec; 205(1):51-8. PubMed ID: 12409184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data.
    Nicholas JA; Electricwala B; Lee LK; Johnson KM
    BMC Neurol; 2019 Oct; 19(1):258. PubMed ID: 31660897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
    Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
    Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.